These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23990120)

  • 1. Stability of benzocaine formulated in commercial oral disintegrating tablet platforms.
    Köllmer M; Popescu C; Manda P; Zhou L; Gemeinhart RA
    AAPS PharmSciTech; 2013 Dec; 14(4):1333-40. PubMed ID: 23990120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process.
    Elnaggar YS; El-Massik MA; Abdallah OY; Ebian AE
    AAPS PharmSciTech; 2010 Jun; 11(2):645-51. PubMed ID: 20405257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of chromatographic methods (HPLC and GC) for the determination of the active components (benzocaine, tyrothricin and menthol) of a pharmaceutical preparation.
    Ortiz-Boyer F; Tena MT; Luque de Castro MD; Valcárcel M
    J Pharm Biomed Anal; 1995 Oct; 13(11):1297-303. PubMed ID: 8634346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.
    Collier JW; Shah RB; Gupta A; Sayeed V; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Jun; 11(2):818-25. PubMed ID: 20454876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Use of Magnesium Oxide as an Excipient to Maintain the Hardness of Orally Disintegrating Tablets during Unpackaged Storage.
    Sakamoto T; Kachi S; Nakamura S; Yuasa H
    Chem Pharm Bull (Tokyo); 2019; 67(3):284-288. PubMed ID: 30828006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gelatin-acacia coacervate containing benzocaine in topical formulations.
    Ichwan AM; Karimi M; Dash AK
    J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
    Wang C; Hu S; Sun CC
    Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorimetric determination of benzocaine, lignocaine and procaine hydrochlorides in pure form and in pharmaceutical formulations using p-benzoquinone.
    Amin AS; el-Didamony AM
    Anal Sci; 2003 Oct; 19(10):1457-9. PubMed ID: 14596417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
    Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
    Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding.
    Rush SD; Vernak C; Zhao F
    Int J Pharm Compd; 2017; 21(1):83-87. PubMed ID: 28346201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
    Patterson J; Bary A; Rades T
    Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content analysis and stability evaluation of selected commercial preparations of St. John's wort.
    Shah AK; Avery BA; Wyandt CM
    Drug Dev Ind Pharm; 2005 Oct; 31(9):907-16. PubMed ID: 16306003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system.
    Gülbağ S; Yılmaz Usta D; Gültekin HE; Oktay AN; Demirtaş Ö; Karaküçük A; Çelebi N
    Pharm Dev Technol; 2018 Jun; 23(5):512-519. PubMed ID: 28657404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.